金域醫學跳水跌6% 員工涉嫌違反傳染病防治法被採取強制措施
格隆匯1月12日丨金域醫學(603882.SH)午後跳水跌6%報90.78元,市值424億元。河南許昌市公安局今日凌晨通報稱,經公安機關調查,鄭州金域臨牀檢驗中心有限公司(金域醫學全資子公司)區域負責人張某東違反傳染病防治法的規定,實施引起新型冠狀病毒感染肺炎傳播或者有傳播嚴重危險的行為。禹州市公安局於2022年1月10日,對張某東以涉嫌刑事犯罪立案偵查井採取強制措施,目前該案正在進一步辦理中。金域醫學午間發公吿迴應稱,正在積極配合對鄭州金域事件進行調查。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.